An Introduction to the TARGIT Quality Collaborative Prospective Registry
Dr. Dennis Holmes
TARGIT - B Update
Dr. Jayant Vaidya
Update of the ExBRT 50KV IORT Multi-Center Registry Study
Dr. Sadia Khan
Session I Q&A
Session II: Non-Breast IORT
Intro
Dr. William Small, Jr.
INTRAGO Trial Update
Dr. Frank Giordano
IORT for Primary and Secondary Brain Tumors
Dr. Ehsan Balagamwala
IORT for Unstable Spine Metastasis
Dr. William Small, Jr.
IORT in Lower GI Malignancies
Dr. Sudha Amarnath
Session III: Oral Abstracts
Intro
Dr. Valery Uhl
Single-institution Evaluation of Local Recurrence Rates Following Intraoperative Radiation Therapy for Breast Cancer
Sarah Schrup
Dosimetric Evaluation and Use of Shielding Materials for Critical Organ Protection in 50 kV Intrabeam Intraoperative Radiation Therapy (IORT)
Dr. Samuel Trichter
Long-term Outcomes for Patients with DCIS Treated with Breast Conservation and Intro-operative Radiotherapy only or Combined with Adjuvant External Beam Radiotherapy
Ms. Kasey Leigh Wood
National Trends for Intra-Operative Radiation Therapy in Favorable, Early Stage Breast Cancer: A Propensity Scoring Analysis of the National Cancer Database
Dr. Mohamad Sebai
Breast IORT in Patients with an Ipsilateral Pacemaker
Dr. Valery Uhl
Utility of Taking Additional Margins when Preforming Breast Conserving Surgery with Intraoperative Radiation Therapy for Early Breast Cancer
Dr. Kristy Broman
Clinical Implementation of a Treatment Planning System Used of INTRABEAM IORT
Dr. Sebastien Gros
Session IV: Biology of IORT
Presidential Address
Dr. Dennis Holmes
TARGIT A & E and Beyond: The Perspective from Radiation Oncology and Biology & How to Establish TARGIT into National Guidelines
Dr. Frederik Wenz
The Rationale Behind Radiobiological Effectiveness, Immune Effects, and Why Immediacy Matters
